July 16, 2020, 05.00 PM

Read also: Indonesia Seeks Partners for Coronavirus Vaccine Production

Those early volunteers developed what is called neutralizing antibodies in their bloodstream — molecules key to blocking infection — at levels comparable to those found in people who survived Covid-19, the research team reported in the New England Journal of Medicine.

“This is an essential building block that is needed to move forward with the trials that could actually determine whether the vaccine does protect against infection,” said Dr. Lisa Jackson of the Kaiser Permanente Washington Research Institute in Seattle, who led the study.

There’s no guarantee but the government hopes to have results around the end of the year — record-setting speed for developing a vaccine.

The vaccine requires two doses, a month apart.

There were no serious side effects, but more than half the study participants reported flu-like reactions to the shots.

Read also: Don't Expect a Covid-19 Vaccine Anytime Soon: Indonesia’s Erick Thohir

The reactions aren’t uncommon with other vaccines — fatigue, headache, chills, fever, and pain at the injection site.

For three participants given the highest dose, those reactions were more severe; that dose isn’t being pursued.

Some of those reactions are similar to coronavirus symptoms but they’re temporary, lasting about a day and occur right after vaccination, researchers noted.

Page:


Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
December 8, 2022, 08.57 PM

Indonesia Detects New Omicron Sub-Variant BN.1

Travel & Leisure
December 6, 2022, 06.37 PM

Indonesia Never Intends to List Widi Islands for Sale

Close Ads